Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01223521|
Recruitment Status : Active, not recruiting
First Posted : October 19, 2010
Last Update Posted : January 17, 2018
|Condition or disease||Intervention/treatment||Phase|
|Contraception||Device: Immediate intrauterine contraception||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||700 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Systematic Provision of Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion. A Randomized, Prospective Trial.|
|Study Start Date :||September 2010|
|Estimated Primary Completion Date :||March 2018|
|Estimated Study Completion Date :||March 2018|
Experimental: Immediate intrauterine contraception
IUD (either Cu-IUD or LNG-IUS) inserted immediately after abortion.
Device: Immediate intrauterine contraception
A Cu-IUD or LNG-IUS is inserted after abortion.
No Intervention: Control group
Post-abortal contraception is prescribed by the hospital but on the responsibility of the patient.
- Number of repeat abortions [ Time Frame: 5 years ]Number of subsequent abortions during five years follow-up time.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01223521
|Dept Obstetrics and Gynecology, Helsinki University Central Hospital|
|Helsinki, Finland, 00029 HUS|
|Principal Investigator:||Oskari Heikinheimo, MD, PhD||Helsinki University Central Hospital|
|Study Director:||Satu P Suhonen, MD, PhD||City of Helsinki|